In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples